证券日报网讯 1月27日，谱尼测试在互动平台回答投资者提问时表示，作为国内综合性检测机构，公司 通过布局生物医药一站式服务CRO/CDMO、医疗器械检测、汽车整车/零部件新能源汽车检测、新能源 汽车动力电池、储能电池检测、电子电气、电器设备检测、新一代通信产品测试、化妆品检测、化妆品 人体功效试验、食品/农产品检测、生态环境监测、绿色低碳管理、高端装备测试、医学检验/病理诊 断、特种设备检验检测业务，全面打造质量基础设施全要素技术体系。 （文章来源：证券日报） ...

Summary of the Conference Call for 华测检测 Industry Overview - The detection industry in China is expected to see a compound annual growth rate (CAGR) of 6% from 2022 to 2024, a slowdown compared to the previous years, but still holds growth potential due to industrial and consumption upgrades [2][3] - The number of industry institutions has decreased for the first time in 20 years, indicating a shift towards self-management capabilities, which may benefit leading companies in terms of market share [2][3] Company Performance - 华测检测, as the first listed detection company in China, has seen its revenue grow nearly tenfold from 2012 to 2024, with a projected revenue of 60.8 billion yuan in 2024 [2][6] - For 2023-2024, revenue growth is expected to slow to 8%-9%, with a 6% revenue increase and a 7% profit increase reported in the first half of the year [2][6] - The third-quarter forecast indicates a year-on-year net profit growth of 10%-13%, marking the first return to double-digit growth in nine quarters [7][19] Segment Performance - The life sciences segment has shown low growth due to a high base from the previous year, while the industrial testing segment has benefited from minimal impact from the real estate sector and new business growth [2][8] - Consumer product testing, particularly in the automotive and semiconductor sectors, is expected to grow significantly, with a 13% revenue increase projected for the first half of 2025 [9][10] Strategic Initiatives - 华测检测 is focusing on lean management and digital upgrades to enhance operational capabilities, with expectations for accelerated profit growth in the fourth quarter and beyond [4][12] - The company is actively pursuing international acquisitions to expand its market presence in Southeast Asia, Africa, and Europe, with several projects already underway [13][14] Management and Efficiency - The company has implemented a professional management team and a comprehensive talent development system, enhancing employee motivation through stock ownership plans and performance targets [15][18] - Efficiency improvements have been significant, with a more than 50% increase in per capita output over recent years, although there is still room for improvement compared to international peers [16][15] Investment Outlook - 华测检测 is viewed as having long-term investment value, with its current valuation being below reasonable levels, offering potential for stable returns for investors [21]

Group 1: Company Performance Overview - In the first half of 2025, the company focused on "maintaining some and reducing others, with moderate expansion," leading to a significant improvement in operating cash flow by 57.35% year-on-year, enhancing capital turnover efficiency [2][3] - Revenue for Q2 2025 increased by 24.38% compared to Q1 2025, while the net profit attributable to shareholders reduced losses by 38.10%, indicating a recovery in operational capabilities [3][17] Group 2: Business Strategy and Focus Areas - The company is actively integrating its core business segments, including food, environment, and medical laboratories, while expanding into emerging sectors like biomedicine and medical devices, which have shown promising revenue growth [2][4] - The long-term goal is to achieve a balanced revenue structure with a 50:50 ratio between chemical and physical testing services, while continuing to deepen traditional sectors like food and environmental testing [4][15] Group 3: Accounts Receivable Management - The company has strengthened accounts receivable management through enhanced credit control and optimized customer structure, implementing tailored collection strategies for major clients to ensure efficient debt recovery [2][3] Group 4: Market Outlook and Growth Opportunities - The company is optimistic about the growth of its biomedicine sector, leveraging its professional capabilities to maintain competitive pricing and increasing order volumes from well-known pharmaceutical companies [4][15] - Plans for overseas expansion are in the pipeline, with a focus on sectors such as electronics, medical devices, food, and automotive, considering acquisitions as a primary mode of entry [6][17] Group 5: Sector-Specific Insights - In the automotive testing sector, the company has achieved an 80% capacity utilization rate, with plans for upgrades to further enhance efficiency and profitability [7][17] - The elevator testing business is expected to maintain sustainability due to regular inspection demands and the growing number of elevators in operation [8][12] Group 6: Future Initiatives and Challenges - The company aims to capitalize on the upcoming business peak in the second half of 2025 by enhancing its overall competitiveness and focusing on high-demand sectors such as biomedicine, medical devices, and special equipment [10][17] - Traditional sectors like food safety and environmental testing will continue to be prioritized, with ongoing commitments to national safety standards and environmental monitoring initiatives [10][12]